These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
45 related items for PubMed ID: 7517079
1. Pediatric intravenous FK506--how much are we really infusing? Firdaous I, Hassoun A, Otte JB, Reding R, de Clety SC, Wallemacq PE. Transplantation; 1994 Jun 27; 57(12):1821-3. PubMed ID: 7517079 [No Abstract] [Full Text] [Related]
2. Whole-blood and plasma levels of FK 506 after liver transplantation: results from the US Multicenter Trial. FK506 Multicenter Study Group. Bäckman L, Levy MF, Klintmalm G. Transplant Proc; 1995 Feb 27; 27(1):1124. PubMed ID: 7533361 [No Abstract] [Full Text] [Related]
3. FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Results from the U.S. Multicenter Trial. McDiarmid SV, Busuttil RW, Ascher NL, Burdick J, D'Alessandro AM, Esquivel C, Kalayoglu M, Klein AS, Marsh JW, Miller CM. Transplantation; 1995 Feb 27; 59(4):530-6. PubMed ID: 7533345 [Abstract] [Full Text] [Related]
4. Effect of using a standard polyvinyl chloride intravenous infusion set on patient response to nitroglycerin. Haas CE, Nowak DR, Mabb WA. Am J Hosp Pharm; 1992 May 27; 49(5):1135-7. PubMed ID: 1595742 [No Abstract] [Full Text] [Related]
5. Different immunosuppressive effects of liposomal FK506 in liver and kidney transplantation. Ko S, Nakajima Y, Kanehiro H, Horikawa M, Yoshimura A, Kido K, Taki J, Aomatsu Y, Kin T, Yagura K, Ohyama T, Ohashi K, Yamada T, Nakano H. Transplant Proc; 1996 Apr 27; 28(2):1066-8. PubMed ID: 8623229 [Abstract] [Full Text] [Related]
6. Administration of tacrolimus in 50 liver transplantation patients. Ye QF, Ruzig MA, Gong NQ. Hepatobiliary Pancreat Dis Int; 2002 Nov 27; 1(4):492-4. PubMed ID: 14607673 [Abstract] [Full Text] [Related]
7. Plasma level-guided low-dose FK 506 therapy in patients with early liver dysfunction after liver transplantation. Winkler M, Ringe B, Jost U, Gubernatis G, Pichlmayr R. Transplant Proc; 1993 Aug 27; 25(4):2688-90. PubMed ID: 7689277 [No Abstract] [Full Text] [Related]
8. Insulin adsorption to polyolefin infusion bottles and polyvinyl chloride administration sets. Hirsch JI, Wood JH, Thomas RB. Am J Hosp Pharm; 1981 Jul 27; 38(7):995-7. PubMed ID: 7020415 [Abstract] [Full Text] [Related]
9. Tacrolimus (FK506): the pros and cons of its use as an immunosuppressant in pediatric liver transplantation. Cox KL, Freese DK. Clin Invest Med; 1996 Oct 27; 19(5):389-92. PubMed ID: 8889279 [Abstract] [Full Text] [Related]
10. Tacrolimus (FK506) and methotrexate as prophylaxis for acute graft-versus-host disease in pediatric allogeneic stem cell transplantation. Yanik G, Levine JE, Ratanatharathorn V, Dunn R, Ferrara J, Hutchinson RJ. Bone Marrow Transplant; 2000 Jul 27; 26(2):161-7. PubMed ID: 10918426 [Abstract] [Full Text] [Related]
11. [Immunosuppression and the problems in partial liver transplantation]. Kawasaki M, Hashikura Y, Matsunami H, Makunouchi M. Nihon Rinsho Meneki Gakkai Kaishi; 1995 Dec 27; 18(6):683. PubMed ID: 8963785 [No Abstract] [Full Text] [Related]
12. Bradycardia associated with intravenous administration of tacrolimus in a liver transplant recipient. Cox TH, Baillie GM, Baliga P. Pharmacotherapy; 1997 Dec 27; 17(6):1328-30. PubMed ID: 9399620 [Abstract] [Full Text] [Related]
16. Diabetogenicity of FK506 versus cyclosporine in liver transplant recipients. Jindal RM, Popescu I, Schwartz ME, Emre S, Boccagni P, Miller CM. Transplantation; 1994 Aug 15; 58(3):370-2. PubMed ID: 7519799 [No Abstract] [Full Text] [Related]
17. Significance of newly developed liposomal FK 506 in canine liver transplantation. Ko S, Nakajima Y, Kanehiro H, Horikawa M, Yoshimura A, Taki J, Kido K, Aomatsu Y, Ueno M, Kin T. Transplant Proc; 1995 Feb 15; 27(1):351-3. PubMed ID: 7533406 [No Abstract] [Full Text] [Related]